Investor Relations

Stock Information


Nasdaq: CTXR




52 week Low/High

Day Low/High

Latest Financial Results

Q2 2019

Quarter Ended Mar 31, 2019

Company Overview

Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius is currently advancing two proprietary product candidates, our Mino-Lok™ product and a hydrocortisone-lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.

Contact Information

Investor Relations
Andrew Scott
VP of Investor Relations
T: 908-967-6677 ext. 105

Transfer Agent
VStock Transfer LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436